Health
Synthetic Mini-Antibody Binds to and Neutralizes SARS-CoV-2 – Technology Networks
Extremely small antibodies, known as nanobodies, have been shown to neutralize SARS-CoV-2. But they’re extracted from llamas and camels, which is problematic for…
Llamas, camels and COVID-19
For SARS-CoV-2 to infect humans, the viral Spike (S) protein must interact with and bind to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of human cells. The S protein achieves this via the receptor binding domains (RBDs), and thus blocking the RBD using antibodies is just one therapeutic avenue that is being explored for the treatment of SARS-CoV-2. Back in May, Technology Networks covered the work of scientists exploring the potential utility of…
-
Noosa News18 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoDoorDash offering Aussies free burgers, burritos, pizzas and meal bundles as an end of year treat
-
General20 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General23 hours agoTownsville man advocates for pancreatic cancer awareness after diagnosis